Statement on Rand Study on Hospital Prices

Tom Nickels
Executive Vice President
American Hospital Association

September 18, 2020 

It is unfortunate that RAND continues to make broad claims about pricing based on a cherry-picked and limited data set. For example, the study again perpetuates erroneous suggestions that Medicare payments should be used as a benchmark for private insurers, in spite of Medicare reimbursing well below the cost of providing care. The authors also rely on research short-cuts. This includes a hand-picked sample of employers and insurers whose claims represent just 0.7% of inpatient admissions and 1.8% of outpatients visits over the study period, as well as measuring quality through Leapfrog data that may be old or imprecise.

These concerns are compounded by a global pandemic that represents the greatest financial threat in history for hospitals and health systems. The case for pulling resources from care providers was weak from the start. It is beyond reckless to advance this approach now.

###

Contact: Marie Johnson, (202) 626-2351, mjohnson@aha.org
                Sean Barry, (202) 626-2306, sbarry@aha.org

 

Related Resources

Letter/Comment
Public
The Medicare Payment Advisory Commission (MedPAC, or the Commission) will vote this month on payment recommendations for 2022.
Special Bulletin
Public
At A Glance Health plans often inappropriately delay or decline coverage for medically necessary care. This can undermine the quality of care that is provided…
Letter/Comment
Public
AHA comments on the Centers for Medicare & Medicaid Services’ proposed changes to the hospital and hospital health care complex cost report.
Letter/Comment
Public
AHA letter urging HHS to exercise enforcement discretion with respect to the hospital price transparency rule.
Letter/Comment
Public
AHA comments on CMS’ proposed rule on prior authorization.
Special Bulletin
Member
A federal appeals court today ruled against AHA’s legal challenge to the Centers for Medicare…